Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Roleca Wacholder is a traditional herbal medicinal product containing juniper oil (*Juniperus communis* aetheroleum) as its active ingredient. Developed and marketed by CGBS, it is primarily indicated for the symptomatic relief of functional dyspepsia and other dyspeptic digestive complaints, such as bloating, flatulence, and mild gastrointestinal spasms. The juniper oil in the formulation acts as a carminative and stomachic agent, stimulating the secretion of gastric juices and bile to facilitate the digestive process. Additionally, it exhibits mild spasmolytic properties on the smooth muscles of the gastrointestinal tract, helping to alleviate discomfort associated with indigestion. The product is typically administered orally in capsule form, providing a standardized dose of the essential oil for therapeutic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Roleca Wacholder.